Ken Griffin Twist Bioscience Corp Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$36.72 - $58.88 $686,664 - $1.1 Million	-18,700 Reduced 44.95%	22,900 $1.03 Million
Q2 2024 Aug 14, 2024	SELL	$27.95 - $53.0 $187,265 - $355,100	-6,700 Reduced 13.87%	41,600 $2.05 Million
Q1 2024 May 15, 2024	BUY	$32.28 - $41.5 $842,508 - $1.08 Million	26,100 Added 117.57%	48,300 $1.66 Million
Q4 2023 Feb 14, 2024	BUY	$15.08 - $38.61 $212,628 - $544,401	14,100 Added 174.07%	22,200 $818,000
Q3 2023 Nov 14, 2023	SELL	$18.62 - $26.57 $461,776 - $658,936	-24,800 Reduced 75.38%	8,100 $164,000
Q2 2023 Aug 14, 2023	BUY	$11.49 - $20.46 $60,897 - $108,438	5,300 Added 19.2%	32,900 $673,000
Q1 2023 May 15, 2023	SELL	$14.6 - $30.9 $426,320 - $902,280	-29,200 Reduced 51.41%	27,600 $416,000
Q4 2022 Feb 14, 2023	BUY	$21.92 - $39.37 $813,232 - $1.46 Million	37,100 Added 188.32%	56,800 $1.35 Million
Q3 2022 Nov 14, 2022	SELL	$33.44 - $56.56 $341,088 - $576,912	-10,200 Reduced 34.11%	19,700 $694,000

258

66.6M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.7B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.